Contact PR

To use this feature, join Babbler easily !

arrow_back

Babbler allows PR people and reporters to collaborate a better way.

By joining Babbler you will be able to access hundreds of newsrooms and PR contacts from your industrie(s) and also share with them your upcoming needs.

Their newsrooms are already on Babbler

You're 1 click away from signing up

Previous

Nice to see you again !

Press release

Bertrand DELUARD appointed President & Chief Executive Officer of the Ethypharm Group
timer minutes reading time minute reading time

Copy link
Ethypharm's Supervisory Board is delighted to announce the appointment of Bertrand Deluard as Group CEO.

Click to get original image size

St-Cloud, France – 31 July 2019 – Ethypharm’s Supervisory Board is delighted to announce the appointment of Bertrand DELUARD as Group President & CEO.

 

Following an announced transitional period, Bertrand DELUARD is taking over from Hugues LECAT who will become President of the Supervisory Board


Bertrand DELUARD, 58, has more than 30 years’ experience and a successful track record within the drugs and medical devices industry, having worked for the biggest groups in France (Rhône Poulenc, Aventis) and internationally (GSK, Johnson & Johnson, Cardinal Health). He has considerable leadership experience in different types of markets in Europe, the United States and in emerging countries. Bertrand is in charge of the Group’s accelerated Transformation, to make Ethypharm a European leader in the domains of CNS and Critical Care.


He stated, “The Ethypharm Group is entering an ambitious new phase of growth and expanding its portfolio of speciality products. I am proud to work alongside the management team and the Group’s 1,400 employees to implement a strategy focusing on the unmet needs of patients & healthcare professionals”.


About Ethypharm

 

Ethypharm is a European-based specialty pharmaceutical Group with global reach. It is a committed player in the domains of CNS (addictions and pain) and Critical Care. These two core therapeutic areas accounted for 64% of our turnover in 2018. The Group has 1,400 employees worldwide, mainly based in France, the United Kingdom, Germany and China and is available for patients in over 80 countries. For over 40 years, Ethypharm’s employees have been making every effort to improve patients’ lives by providing high-quality drugs to respond to unmet medical needs. Ethypharm works closely with healthcare professionals and authorities to ensure appropriate use and access to its drugs for as many as possible all around the world.

For more information about the Ethypharm Group, go to http://www.ethypharm.com and follow @ethypharm on Linkedin.


Press contact – Avril PONNELLE /presse@ethypharm.com/+ 33 (0) 1 41 12 17 20

inscrit avec succès

Congratulations, you're registered on Babbler!

Discover now all the news waiting for you on Babbler: visit your newsfeed.!

Your topics have been selected, you can change it by clicking here